Research Analysts Set Expectations for Teleflex Incorporated’s FY2018 Earnings (TFX)

Teleflex Incorporated (NYSE:TFX) – Analysts at Leerink Swann upped their FY2018 earnings estimates for shares of Teleflex in a report issued on Thursday. Leerink Swann analyst R. Newitter now expects that the medical technology company will post earnings per share of $9.66 for the year, up from their previous forecast of $9.64. Leerink Swann has a “Outperform” rating and a $266.00 price objective on the stock. Leerink Swann also issued estimates for Teleflex’s FY2019 earnings at $11.37 EPS.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.01 by $0.11. The firm had revenue of $534.70 million during the quarter, compared to analyst estimates of $522.94 million. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. Teleflex’s revenue was up 17.3% compared to the same quarter last year. During the same period last year, the business posted $1.80 earnings per share.

ILLEGAL ACTIVITY WARNING: “Research Analysts Set Expectations for Teleflex Incorporated’s FY2018 Earnings (TFX)” was first posted by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.com-unik.info/2017/11/06/research-analysts-set-expectations-for-teleflex-incorporateds-fy2018-earnings-tfx.html.

Several other analysts also recently issued reports on TFX. Morgan Stanley lifted their price target on shares of Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research report on Friday. Jefferies Group LLC lifted their price target on shares of Teleflex from $270.00 to $295.00 and gave the company a “buy” rating in a research report on Friday. BidaskClub downgraded shares of Teleflex from a “hold” rating to a “sell” rating in a research report on Tuesday, August 8th. Needham & Company LLC lifted their price target on shares of Teleflex from $237.00 to $285.00 and gave the company a “buy” rating in a research report on Friday. Finally, Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $232.00 price target for the company in a research report on Friday, September 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $271.88.

Teleflex (NYSE:TFX) traded down $0.33 during trading on Monday, reaching $256.08. The company’s stock had a trading volume of 59,449 shares, compared to its average volume of 232,739. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70. The company has a market capitalization of $11,551.08, a price-to-earnings ratio of 31.69, a PEG ratio of 2.47 and a beta of 1.05.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Neuberger Berman Group LLC raised its stake in shares of Teleflex by 0.5% during the 2nd quarter. Neuberger Berman Group LLC now owns 5,708 shares of the medical technology company’s stock worth $1,186,000 after purchasing an additional 28 shares during the period. Stifel Financial Corp raised its stake in shares of Teleflex by 0.6% during the 2nd quarter. Stifel Financial Corp now owns 5,399 shares of the medical technology company’s stock worth $1,121,000 after purchasing an additional 31 shares during the period. Toronto Dominion Bank raised its stake in shares of Teleflex by 14.5% during the 2nd quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 70 shares during the period. Xact Kapitalforvaltning AB raised its stake in shares of Teleflex by 2.7% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 3,482 shares of the medical technology company’s stock worth $723,000 after purchasing an additional 90 shares during the period. Finally, World Asset Management Inc raised its stake in shares of Teleflex by 3.6% during the 2nd quarter. World Asset Management Inc now owns 2,942 shares of the medical technology company’s stock worth $611,000 after purchasing an additional 101 shares during the period. Institutional investors own 89.79% of the company’s stock.

In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $241.88, for a total transaction of $48,376.00. Following the transaction, the director now directly owns 8,080 shares of the company’s stock, valued at approximately $1,954,390.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold a total of 600 shares of company stock worth $138,162 over the last ninety days. Insiders own 2.39% of the company’s stock.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Wednesday, November 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date of this dividend is Tuesday, November 14th. Teleflex’s dividend payout ratio is 24.82%.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Earnings History and Estimates for Teleflex (NYSE:TFX)

What are top analysts saying about Teleflex Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teleflex Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit